- Home
- FVRR vs BBNX Comparison
FVRR vs BBNX Comparison
Compare FVRR & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FVRR | BBNX |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | Israel | United States |
| Employees | N/A | 409 |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.3M | 610.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | FVRR | BBNX |
|---|---|---|
| Price | $11.09 | $13.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $18.38 | ★ $26.73 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.34 | $35.03 |
| Revenue Next Year | $7.10 | $33.24 |
| P/E Ratio | $22.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.25 | $8.89 |
| 52 Week High | $34.13 | $32.71 |
Technical Indicators
Market Signals| Indicator | FVRR | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 21.35 | 33.21 |
| Support Level | N/A | $12.48 |
| Resistance Level | $22.61 | $15.64 |
| Average True Range (ATR) | 0.99 | 1.17 |
| MACD | -0.34 | 0.46 |
| Stochastic Oscillator | 9.41 | 52.02 |
Price Performance
Historical ComparisonAbout FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.